AU SFB’s (AU) Q4FY23 has been an eventful quarter – while it continues to deliver robust financial performance as reflected in RoA reaching 2% and RoE at ~16%, re- appointment of Mr. Sanjay Agarwal as MD & CEO and Mr. Uttam Tibrewal as whole- time director for three years (w.e.f. from 19th Apr’23 to 18th Apr’26) and AD-1 license approval testify its successful SFB journey.